These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6254356)
1. The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone. Schecter A Am J Drug Alcohol Abuse; 1980; 7(1):1-18. PubMed ID: 6254356 [No Abstract] [Full Text] [Related]
2. The sequential use of clonidine and naltrexone in the treatment of opiate addicts. Gold MS; Dackis CA; Washton AM Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273 [TBL] [Abstract][Full Text] [Related]
3. Naltrexone, opiate addiction, and endorphins. Gold MS; Dackis CA; Pottash AL; Sternbach HH; Annitto WJ; Martin D; Dackis MP Med Res Rev; 1982; 2(3):211-46. PubMed ID: 6289026 [No Abstract] [Full Text] [Related]
4. Action of naloxone and naltrexone in different types of psychoses. Volavka J Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726 [No Abstract] [Full Text] [Related]
5. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122 [TBL] [Abstract][Full Text] [Related]
6. Nontolerance to the opioid antagonism of naltrexone. Kleber HD; Kosten TR; Gaspari J; Topazian M Biol Psychiatry; 1985 Jan; 20(1):66-72. PubMed ID: 2981129 [TBL] [Abstract][Full Text] [Related]
8. Abstinence treatments for opiate addicts: therapeutic community or naltrexone? Arndt I; McLellan AT; O'Brien CP NIDA Res Monogr; 1984 Mar; 49():275-81. PubMed ID: 6434972 [No Abstract] [Full Text] [Related]
9. Clinical experiences with naltrexone in 370 detoxified addicts. Thomas M; Kauders F; Harris M; Cooperstein J; Hough G; Resnick R NIDA Res Monogr; 1976 Sep; (9):88-92. PubMed ID: 794726 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological advances in addiction treatment. Preston KL; Bigelow GE Int J Addict; 1985; 20(6-7):845-67. PubMed ID: 2867050 [TBL] [Abstract][Full Text] [Related]
12. Strategies to improve compliance with narcotic antagonists. Kosten TR; Kleber HD Am J Drug Alcohol Abuse; 1984; 10(2):249-66. PubMed ID: 6475891 [TBL] [Abstract][Full Text] [Related]
13. Naltrexone-induced dysphoria in former opioid addicts. Crowley TJ; Wagner JE; Zerbe G; Macdonald M Am J Psychiatry; 1985 Sep; 142(9):1081-4. PubMed ID: 2992300 [TBL] [Abstract][Full Text] [Related]
14. Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog. Pace NL; Wong KC Anesth Analg; 1979; 58(1):36-9. PubMed ID: 219728 [TBL] [Abstract][Full Text] [Related]
15. Methadone-induced endorphin dysfunction in addicts. Gold MS; Pottash AC; Extein I; Martin D; Kleber HD NIDA Res Monogr; 1982 Apr; 41():476-82. PubMed ID: 6289119 [No Abstract] [Full Text] [Related]
16. Clinical experience with naltrexone in suburban opioid addicts. Tennant FS; Rawson RA; Cohen AJ; Mann A J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935 [TBL] [Abstract][Full Text] [Related]
18. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification]. Jovanović T; Lazarević D; Nikolić G Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424 [TBL] [Abstract][Full Text] [Related]
19. Update of naltrexone treatment. O'Brien CP; Greenstein R; Woody GE NIDA Res Monogr; 1978; (19):315-20. PubMed ID: 218107 [TBL] [Abstract][Full Text] [Related]
20. Opiate addiction and plasma beta-endorphin-like immunoreactivity: methadone maintained, recently detoxified and early naltrexone treated ex-addicts. Cushman P; Morris D; Adams M; Dewey W Alcohol Drug Res; 1987; 7(5-6):533-40. PubMed ID: 2956960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]